Showing results (31-40 of 276) with videos related to
Sort By:
Pageof 28
Developmental Disabilities Research Reviews|June 26, 2013
Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screeningSusan E Waisbren, Yuval Landau, Jenna Wilson, et al.Plos One|August 12, 2010
Women have higher protein content of beta-oxidation enzymes in skeletal muscle than menAmy C Maher, Mahmood Akhtar, Jerry Vockley, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|November 30, 2022
Scaling genetic resources: New paradigms for diagnosis and treatment of rare genetic diseaseJerry Vockley, Thomas Defay, Aaron J Goldenberg, et al.Journal of Inherited Metabolic Disease|July 1, 2026
Immune Dysregulation in Branched Chain Organic AcidemiasAbdul L Shakerdi, Jack Drda, Justin A Dutta, et al.Pediatric Radiology|October 5, 2018
Differential diagnosis of perinatal hypophosphatasia: radiologic perspectivesAmaka C Offiah, Jerry Vockley, Craig F Munns, et al.Molecular Genetics and Metabolism|December 27, 2005
Functional analysis of acyl-CoA dehydrogenase catalytic residue mutants using surface plasmon resonance and circular dichroismEric S Goetzman, Miao He, Tien V Nguyen, et al.The Journal of Biological Chemistry|April 30, 2003
Mechanism-based inactivation of human glutaryl-CoA dehydrogenase by 2-pentynoyl-CoA: rationale for enhanced reactivityK Sudhindra Rao, Mark Albro, Jerry Vockley, et al.Trends in Endocrinology and Metabolism: TEM|May 29, 2012
Therapies in inborn errors of oxidative metabolismManuel Schiff, Paule Bénit, Howard T Jacobs, et al.Molecular Genetics and Metabolism|November 13, 2012
Evidence for involvement of medium chain acyl-CoA dehydrogenase in the metabolism of phenylbutyrateKaitlyn Kormanik, Heejung Kang, Dean Cuebas, et al.Biochemical Pharmacology|January 29, 2023
Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disordersBianca Seminotti, Mateus Grings, Nícolas Manzke Glänzel, et al.Pageof 28